Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2020 Nov;25(11):1210-1211.
doi: 10.1111/resp.13940. Epub 2020 Sep 20.

Reply

Stefano Savinelli  1   2 , Cormac McCarthy  3   4 , Patrick W Mallon  1   2 ; All Ireland Infectious Diseases (AIID) Cohort Collaborators
Affiliations
Comment

Reply

Stefano Savinelli et al. Respirology. 2020 Nov.

Abstract

See related letter

PubMed Disclaimer

Figures

Figure 1
Figure 1
Clinical trial plan. Brief description of patient population (top left). Description of the two stages of the clinical trial (stage 1 and stage 2), with definition of the two study arms for each stage.
See this image and copyright information in PMC

Comment on

References

    1. McCarthy C, Savinelli S, Feeney ER, Butler MW, O'Broin C, Ryan S, O'Neill L, Murphy DJ, Gallagher CG, McKone EF et al. Tocilizumab therapy in individuals with COVID‐19 infection and hyperinflammatory state. Respirology 2020. 10.1111/resp.13912. - DOI - PMC - PubMed
    1. Sinha P, Mostaghim A, Bielick CG, McLaughlin A, Hamer DH, Wetzler L, Bhadelia N, Fagan M, Linas BP, Assoumou SA et al. Early administration of interleukin‐6 inhibitors for patients with severe Covid‐19 disease is associated with decreased intubation, reduced mortality, and increased discharge. Int. J. Infect. Dis. 2020; 99: 28–33. 10.1016/j.ijid.2020.07.023. - DOI - PMC - PubMed
    1. Quartuccio L, Sonaglia A, Pecori D, Peghin M, Fabris M, Tascini C, De Vita S. Higher levels of IL‐6 early after tocilizumab distinguish survivors from nonsurvivors in COVID‐19 pneumonia: a possible indication for deeper targeting of IL‐6. J. Med. Virol. 2020. 10.1002/jmv.26149. - DOI - PMC - PubMed
    1. Langford BJ, So M, Raybardhan S, Leung V, Westwood D, MacFadden DR, Soucy JR, Daneman N. Bacterial co‐infection and secondary infection in patients with COVID‐19: a living rapid review and meta‐analysis. Clin. Microbiol. Infect. 2020. 10.1016/j.cmi.2020.07.016. - DOI - PMC - PubMed
    1. Giacobbe DR, Battaglini D, Ball L, Brunetti I, Bruzzone B, Codda G, Crea F, De Maria A, Dentone C, Di Biagio A et al. Bloodstream infections in critically ill patients with COVID‐19. Eur. J. Clin. Invest. 2020: 10.1111/eci.13319. - DOI - PMC - PubMed